Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2021-07-23 00:00:00 ET · period of report 2021-07-22 · accession 0000899243-21-029687 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-23 | 2021-07-22 | HRMY | Dayno Jeffrey M. | Chief Medical Off | S - Sale+OE | $30.00 | -50 | 0 | -100% | -$1,500 |
| D | 2021-07-23 | 2021-07-22 | HRMY | Dayno Jeffrey M. | Chief Medical Off | M - OptEx | $8.22 | +50 | 50 | New | +$411.00 |
| D | 2021-07-23 | 2021-07-22 | HRMY | Dayno Jeffrey M. | Chief Medical Off | M - OptEx | $0.00 | -50 | 103.4K | -0.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-22 | S | D | 50 | $30.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-22 | M | A | 50 | $8.22 | 50 | D | — | — | |
| 3 | Derivative | Stock Option | 2021-07-22 | M | D | 50 | $0.00 | 103,419 | D | $8.22 · — to 2027-11-13 | 50 Common Stock | (F2) The stock option is currently vested with respect to 82,777 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 13, 2021. |